SCHEMBL60621

SCHEMBL60621

C=Cc1cccc(O)c1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.67
CA2 P00918 3/20 0.67
MAPT P10636 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
THRB P10828 1/20 0.43
BACE1 P56817 1/20 0.43
APP P05067 1/20 0.43
KDM4E B2RXH2 3/20 0.42
TP53 P04637 2/20 0.42
MAPK1 P28482 2/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16951902 0.85 CA1 (0.45) CA1CA2MAPTALDH1A1KDM4E
SCHEMBL16952390 0.82 CA1 (0.69) CA1CA2MAPTALDH1A1MEN1
SCHEMBL9464894 0.82 CA1 (0.44) CA1CA2ALDH1A1TDP1CYP3A4
SCHEMBL28576325 0.81 CA1 (0.62) CA1CA2MAPTALDH1A1MEN1
SCHEMBL16958506 0.80 CA1 (0.43) CA1CA2MAPTALDH1A1MEN1
SCHEMBL3021082 0.80 CA1 (0.67) CA1CA2MAPTALDH1A1MEN1
SCHEMBL470709 0.80 CA1 (1.00) CA1CA2MAPTALDH1A1MEN1
SCHEMBL16959774 0.79 CA1 (0.43) CA1CA2MAPTALDH1A1MEN1
SCHEMBL16989324 0.78 CA1 (0.65) CA1CA2MAPTALDH1A1MEN1
SCHEMBL16989326 0.78 CA1 (0.65) CA1CA2MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 633 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
CN-118405686-B Preparation method and application of lignin-based resin and carbon material for battery 山东圣泉新能源科技有限公司 2025-04-18 CN claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
EP-3828155-B1 PROCESS FOR THE PRODUCTION OF FUNCTIONALISED STYRENE MONOMERS FROM BENZENE OR AROMATIC OXYGENATES KEMIJSKI INST (SI) 2025-02-12 EP claimed
CN-118405685-B Preparation method and application of lignin-based resin and carbon material for battery 山东圣泉新能源科技有限公司 2025-01-10 CN claimed
CN-119255781-A Antimicrobial mixtures 西姆莱斯股份公司 2025-01-03 CN claimed
EP-4472606-A1 COMPOSITIONS (III) Symrise AG (DE) 2024-12-11 EP claimed
US-20240358611-A1 COMPOSITIONS SYMRISE AG (DE) 2024-10-31 US claimed
CN-118829416-A Composition (III) 西姆莱斯股份公司 2024-10-22 CN claimed
WO-2000047179-A1 SKIN LIGHTENING AGENTS ZYLEPSIS LIMITED (GB) 2000-08-17 WO claimed
WO-2000047758-A2 METHODS OF MAKING COMPOUNDS ZYLEPSIS LIMITED (GB) 2000-08-17 WO claimed
CN-1261620-A Defoaming composition for diesel oil CK VITCO CORP (US) 2000-08-02 CN claimed
US-6093222-A SYNERGISTIC BLEND OF LOW TO MODERATE MOLECULAR WEIGHT SILICONE WHICH ARE MORE SOLUBLE IN THE BLEND OF ADDITIVES ADDED TO THE PETROLEUM PRODUCT AT A REFINERY; MOTOR VEHICLE ENGINES; HYDROSILATED POLYSILOXANES; POLYETHERSILOXANES CK WITCO CORPORATION (US) 2000-07-25 US claimed
EP-1010748-A1 Diesel fuel antifoam composition CK WITCO CORPORATION (US) 2000-06-21 EP claimed
EP-0416713-B2 Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained DSM NV (NL) 1999-06-23 EP claimed
US-5573926-A HYDROLYSIS GIST-BROCADES, N.V. (NL) 1996-11-12 US claimed
WO-1991003174-A1 PROCESS FOR OBTAINING AROMA COMPONENTS AND AROMAS FROM THEIR PRECURSORS OF A GLYCOSIDIC NATURE, AND AROMA COMPONENTS AND AROMAS THEREBY OBTAINED GIST-BROCADES N.V. (NL) 1991-03-21 WO claimed
EP-0416713-A1 Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained GIST-BROCADES N.V. (NL) 1991-03-13 EP claimed
US-4927805-A Hydrolysis of curcumin MALLINCKRODT, INC. (US) 1990-05-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240358611-A1 COMPOSITIONS AZI2, NISCH, CIP2A CA1 3077/4885CA2 3123/4885MAPT 4101/4885
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 CA1 4319/4885CA2 3362/4885MAPT 2244/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 CA1 4061/4885CA2 3302/4885MAPT 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.